Provenge, the first immunotherapy drug to receive FDA approval for use in patients, had its origins decades ago in the lab of Edgar Engleman. Photo by Timothy Archibald /2019
sp19 provenge twitter
Popular posts
What’s the deal with the gut-brain connection?
Stanford Medicine researchers describe the gut-brain relationship and how it affects conditions from anxiety to long COVID to Parkinson’s.
What’s the deal with red light therapy?
Photobiomodulation, the use of light waves to change human biology, has boomed in recent years for all kinds of purposes, at medical clinics and at home. We wanted to know what the science says — and doesn’t say.